Victory Capital Management
ENZ

Victory Capital Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Victory Capital Management’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-14,004
Closed -$36K – 3352
2020
Q1 		$36K Buy
+14,004
New +$34.4K ﹤0.01% 2898
2019
Q4 		– Sell
-7,060
Closed -$25K – 3342
2019
Q3 		$25K Buy
+7,060
New +$25K ﹤0.01% 2968

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Victory Capital Management's ENZ Position: Q2 2020 in Review

Victory Capital Management sold out of Enzo Biochem, Inc. (ENZ) in Q2 2020, closing a stake of 14,004 shares — an estimated $36K sold.

Victory Capital Management first reported a position in ENZ in Q3 2019 and held it in 2 quarters. The position peaked at $36K in Q1 2020. 84 funds tracked by Wall St. Rank hold ENZ as of Q2 2020.

  • Victory Capital Management reported no remaining Enzo Biochem, Inc. position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 14,004 Enzo Biochem, Inc. shares in Q2 2020, an estimated $36K.
  • Victory Capital Management first reported a position in Enzo Biochem, Inc. in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Enzo Biochem, Inc. position peaked at $36K in Q1 2020.
  • 84 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.